+$452.1K
Net Activity
Institutions Holding
22
Popularity Rank
#7990
Avg Weight
0.00%
Total Value
$1.8M
22 institutions currently hold VVOS, with 9 net buyers and 4 net sellers this quarter.
Institutional Moves (Q1 2026)
Majority Increased
Based on recent trading activity
Net Selling Institutions
4
Net Buying Institutions
9
Top 5 by Value
+$1.6M
Total Buy Value
$349.7K
Total Sell Value
9
Net Buyers
4
Net Sellers
No Form 144 planned sale filings in the last 90 days
No Schedule 13D/13G filings for this ticker
1
Filings (14d)
Vivos Therapeutics entered into a securities purchase agreement with two investors to raise $2.1 million. The company sold preferred stock and warrants at $0.582 per unit. About $1 million came from cash, and another $1 million came from converting a previous bridge loan. Warrants are exercisable at $0.456 per share for five years.
View Full Filing (SEC EDGAR)The most-added stocks by 13F institutions this quarter
Institutions Holding
6,150
Total reported value
$2.1T
3245 13F institutions increased their position this quarter
Institutions Holding
5,957
Total reported value
$1.5T
3028 13F institutions increased their position this quarter
Institutions Holding
5,764
Total reported value
$3.0T
2743 13F institutions increased their position this quarter